Studies on the Mechanism of Alloxan-diabetes Potentiation of Carbon Tetrachloride-induced Liver Necrosis

Overview

Journal Br J Exp Pathol

Specialty Pathology

Date 1982 Aug 1

PMID 6758834

Citations 2

Authors

M C Villarruel

G Fernandez

E C de Ferreyra

O M de Fenos

J A Castro

Affiliations

Soon will be listed here.

Abstract

Carbon tetrachloride (CCl4)-induced liver necrosis in alloxan diabetic rats is markedly more intense than in controls as established by determination of isocitric dehydrogenase activity in plasma or by histological techniques. The covalent binding (CB) of CCl4 reactive metabolites to liver microsomal lipids is higher in alloxan diabetic rats than in controls. Cytochrome c reductase activity remains unchanged in alloxan diabetic rats. All the alterations described above observed in the diabetic animals are reverted by insulin administration. CCl4-induced lipid peroxidation of microsomal lipids, in contrast, is equally intense in controls than in alloxan diabetic animals and it is not modified by insulin treatment. Body temperature in alloxan diabetic animals treated with CCl4 is lower than in controls treated with the hepatotoxin. Results suggest that part of the enhanced necrogenic response of the liver observed in alloxan diabetic rats is due to increased CB to liver cell constituents but available evidence from the present and another work suggest that increased susceptibility of the liver from alloxan diabetic animals play a major role in the potentiation of CCl4 deleterious effects.

Citing Articles

In Vitro & In Vivo Anti-Hyperglycemic Potential of Saponins Cake and Argan Oil from .

Kamal R, Kharbach M, Vander Heyden Y, Yu H, Bouklouze A, Cherrah Y Foods. 2021; 10(5).

PMID: 34068075 PMC: 8152476. DOI: 10.3390/foods10051078.

Arachidonic acid metabolism in galactosamine/endotoxin induced acute liver injury in rats.

Meng X, Wang J J Tongji Med Univ. 1994; 14(3):169-72.

PMID: 7807604 DOI: 10.1007/BF02886800.

References

Slater T . Necrogenic action of carbon tetrachloride in the rat: a speculative mechanism based on activation. Nature. 1966; 209(5018):36-40. DOI: 10.1038/209036a0. View

Schenkman J, Remmer H, Estabrook R . Spectral studies of drug interaction with hepatic microsomal cytochrome. Mol Pharmacol. 1967; 3(2):113-23. View

RECKNAGEL R . Carbon tetrachloride hepatotoxicity. Pharmacol Rev. 1967; 19(2):145-208. View

McLean A . The effect of diet and vitamin E on liver injury due to carbon tetrachloride. Br J Exp Pathol. 1967; 48(6):632-6. PMC: 2093852. View

Klaassen C, Plaa G . Comparison of the biochemical alterations elicited in livers from rats treated with carbon tetrachloride, chloroform, 1,1,2-trichloroethane and 1,1,1-trichloroethane. Biochem Pharmacol. 1969; 18(8):2019-27. DOI: 10.1016/0006-2952(69)90299-8. View

Castro J, Cignoli E, de Castro C, de Fenos O . Prevention by cystamine of liver necrosis and early biochemical alterations induced by carbon tetrachloride. Biochem Pharmacol. 1972; 21(1):49-57. DOI: 10.1016/0006-2952(72)90249-3. View

Castro J, Gomez M . Studies on the irreversible binding of 14 C-CCl 4 to microsomal lipids in rats under varying experimental conditions. Toxicol Appl Pharmacol. 1972; 23(4):541-52. DOI: 10.1016/0041-008x(72)90095-6. View

Castro J, de Ferreyra E, de Castro C, Diaz Gomez M, DaCosta N, de Fenos O . Studies on the mechanism of cystamine prevention of several liver structural and biochemical alterations caused by carbon tetrachloride. Toxicol Appl Pharmacol. 1973; 24(1):1-19. DOI: 10.1016/0041-008x(73)90176-2. View

Diaz Gomez M, Castro J, de Ferreyra E, DaCosta N, de Castro C . Irreversible binding of 14C from 14CCl4 to liver microsomal lipids and proteins from rats pretreated with compounds altering microsomal mixed-function oxygenase activity. Toxicol Appl Pharmacol. 1973; 25(4):534-41. DOI: 10.1016/0041-008x(73)90022-7. View

10.

Rechnagel R, Glende Jr E . Carbon tetrachloride hepatotoxicity: an example of lethal cleavage. CRC Crit Rev Toxicol. 1973; 2(3):263-97. DOI: 10.3109/10408447309082019. View

11.

Hanasono G, Cote M, Plaa G . Potentiation of carbon tetrachloride-induced hepatotoxicity in alloxan- or strepto- zotocin-diabetic rats. J Pharmacol Exp Ther. 1975; 192(3):592-604. View

12.

Hanasono G, Witschi H, Plaa G . Potentiation of the hepatotoxic responses to chemicals in alloxan-diabetic rats. Proc Soc Exp Biol Med. 1975; 149(4):903-7. DOI: 10.3181/00379727-149-38924. View

13.

Diaz Gomez M, de Castro C, DaCosta N, de Fenos O, de Ferreyra E, Castro J . Species differences in carbon tetrachloride-induced hepatotoxicity: the role of CCl4 activation and of lipid peroxidation. Toxicol Appl Pharmacol. 1975; 34(1):102-14. DOI: 10.1016/0041-008x(75)90179-9. View

14.

Reinke L, Stohs S, Rosenberg H . Altered activity of hepatic mixed-function mono-oxygenase enzymes in streptozotocin-induced diabetic rats. Xenobiotica. 1978; 8(10):611-9. DOI: 10.3109/00498257809069573. View

15.

Past M, Cook D . Alterations in hepatic microsomal cytochrome P-450 hemeproteins in diabetic rats. Res Commun Chem Pathol Pharmacol. 1980; 27(2):329-37. View

16.

Bernacchi A, de Castro C, de Toranzo E, Marzi A, de Ferreyra E, de Fenos O . Pyrazole prevention of CC14-induced ultrastructural changes in rat liver. Br J Exp Pathol. 1980; 61(5):505-11. PMC: 2041540. View

17.

LOWRY O, ROSEBROUGH N, FARR A, RANDALL R . Protein measurement with the Folin phenol reagent. J Biol Chem. 1951; 193(1):265-75. View

18.

STERKEL R, Spencer J, WOLFSON Jr S, WILLIAMS-ASHMAN H . Serum isocitric dehydrogenase activity with particular reference to liver disease. J Lab Clin Med. 1958; 52(2):176-84. View

19.

Williams Jr C, KAMIN H . Microsomal triphosphopyridine nucleotide-cytochrome c reductase of liver. J Biol Chem. 1962; 237:587-95. View

20.

DIXON R, HART L, Rogers L, Fouts J . THE METABOLISM OF DRUGS BY LIVER MICROSOMES FROM ALLOXAN-DIABETIC RATS: LONG TERM DIABETES. J Pharmacol Exp Ther. 1963; 142:312-7. View